Triple-Negative Breast Cancer (TNBC) Withdrawn Phase Trials for Azacitidine (DB00928)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01292083Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By SurgeryTreatment